Background Lung cancer is the deadliest and most diagnosed type of cancer worldwide.
The 5-year survival rate of lung adenocarcinoma (LUAD) dropped significantly when tumor …

Statins are suggested to improve cancer survival by possible anti‐inflammatory effect.
However, it remains unclear if concomitant use of statins could improve the efficacy of …

Background STK11/LKB1 mutations have been associated with primary resistance to PD-1
axis inhibitors and poor prognosis in advanced KRAS-mutant lung adenocarcinoma. This …

Background: In recent years, reduction of nuclear power generation and the use of coal-fired
power for filling the power supply gap might have increased the risk of lung cancer. This …

Background The role of adjuvant therapy in completely resected primary tumors that have
components of both non–small cell lung cancer and small cell lung cancer (combined …

Background Immunotherapy has been proved to have a large effect on extensive‐stage
small cell lung cancer, but the role of immunotherapy in limited‐stage small‐cell lung cancer …

La evidencia científica durante las últimas 2 décadas respalda que la aplicación de técnicas
de cribado de cáncer de pulmón mediante tomografía computarizada (TC) de tórax de baja …

La evidencia científica durante las últimas 2 décadas respalda que la aplicación de técnicas
de cribado de cáncer de pulmón mediante tomografía computarizada (TC) de tórax de baja …

Background: The use of immune checkpoint inhibitors (ICIs) in patients with advanced lung
cancer is increasing. Despite ongoing studies to predict the efficacy of ICIs, its use in clinical …

Mucosal-associated invariant T cells (MAITs) represent a subset of innate-like
unconventional T cells pivotal in safeguarding mucosal immunity. MAIT cells possess …